Douglas Blayney
Direktor/Vorstandsmitglied bei ARTELO BIOSCIENCES, INC.
Vermögen: 1 118 $ am 30.04.2024
Aktive Positionen von Douglas Blayney
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARTELO BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 31.07.2017 | - |
Independent Dir/Board Member | 31.07.2017 | - | |
Stanford University | Corporate Officer/Principal | 01.07.2010 | - |
Karriereverlauf von Douglas Blayney
Ehemalige bekannte Positionen von Douglas Blayney
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Stanford Cancer Institute | Corporate Officer/Principal | 01.07.2010 | 01.07.2015 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Präsident | 01.06.2009 | 01.07.2010 |
University of Michigan Comprehensive Cancer Center | Technik-/Wissenschafts-/F&E-Leiter | 01.07.1999 | 01.06.2003 |
Asco Quality Symposium | Gründer | - | - |
Ausbildung von Douglas Blayney
University of California | Undergraduate Degree |
Stanford University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Undergraduate Degree | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ARTELO BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Stanford Cancer Institute | |
Asco Quality Symposium |
- Börse
- Insiders
- Douglas Blayney
- Erfahrung